Published in

Wiley Open Access, Clinical Case Reports, 10(3), p. 790-792, 2015

DOI: 10.1002/ccr3.342

Links

Tools

Export citation

Search in Google Scholar

Anticoagulant therapy with rivaroxaban in a young patient with paroxysmal nocturnal hemoglobinuria

Journal article published in 2015 by Francesco Dragoni, Flavia Chiarotti ORCID, Laura Lombardi, Anna Paola Iori, Arturo Cafolla
This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Green circle
Preprint: archiving allowed
Upload
Green circle
Postprint: archiving allowed
Upload
Green circle
Published version: archiving allowed
Upload
Policy details
Data provided by SHERPA/RoMEO

Abstract

The new direct oral anticoagulants such us rivaroxaban, could play an important role in the anticoagulant treatment of patients with paroxysmal nocturnal hemoglobinuria where anticoagulant treatment is complex to run, since they have shown a reduction in serious bleeding complications compared to antithrombotic therapy with classical vitamin k antagonist.